Longevity evidence / “Longevity peptides”

Do peptides like epitalon, MOTS-c and humanin slow aging?

Our verdictMostly preclinical
PreclinicalEarly humanControlled trialsApproved use

Background

A group of research peptides is promoted online for anti-aging, including epitalon, MOTS-c, humanin, SHLP2 and SS-31. Several come from mitochondrial biology or Russian pineal research.

What the human research shows

  • Most evidence comes from cell and animal studies.
  • Human data are mostly observational (for example, blood levels falling with age) or from small studies by a single research group.
  • SS-31 (elamipretide) is the exception, with randomized trials in specific mitochondrial diseases, not in aging.

What we still don’t know

  • Whether any of them extend healthspan or lifespan in people.
  • Long-term safety, dosing and the quality of products sold online.

Safety and status

None is approved as an anti-aging treatment. Since October 2026, some (including epitalon and MOTS-c) may be compounded by licensed pharmacies under FDA enforcement discretion, which is not approval.

Sources

  1. VALREXA research area: Longevity & aging
  2. VALREXA news: FDA compounding decision
Cite this page

VALREXA Biosciences. (2026, November 7). Do peptides like epitalon, MOTS-c and humanin slow aging?. VALREXA Biosciences. https://valrexa.com/longevity/longevity-peptides.html

APA style · Last reviewed November 7, 2026 · Our editorial standards

Last reviewed November 7, 2026. Educational only; not medical advice, and not a recommendation to take any drug or supplement. Talk to a clinician before starting anything.

Related profiles

Put your understanding to work

Choose a next step, at your own pace.